🔎 Trials Near Me

Akèy › Leukemi › Connecticut › New Haven

Etid klinik pou Leukemi nan New Haven, CT

8 etid pou Leukemi ap chèche patisipan nan sit nan ak bò kote New Haven (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Ap rekriteFaz 3
  • Yale University School of Medicine, New Haven
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Ap rekriteFaz 1
  • Smilow Cancer Hospital at Yale New Haven, New Haven
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06001788

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Ap rekriteFaz 1/2
  • Dren Investigational Site, New Haven
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Ap rekriteEtid obsèvasyon
  • Yale University, New Haven
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Ap rekriteFaz 2/3
  • Yale University, New Haven
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317

Revumenib in Combination With 7+3 + Midostaurin in AML

Ap rekriteFaz 1
  • Yale Cancer Center, New Haven
Laj 18 a 75 · Tout sèks · Mizajou Mar 25, 2026 · NCT06313437

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Ap rekriteFaz 1
  • Yale Cancer Center and Smilow Cancer Hospital, New Haven
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT05735184

Etid Leukemi nan lòt vil

Lòt etid nan New Haven

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.